Chapter 5 - Mental, Behavioral and Neurodevelopmental disorders (F01-F99)»Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders (F20-F29)»Delusional disorders (F22)

F22

Delusional disorders

Related indications (MeSH) (3)

Major Depressive Disorder356 drugs (187 approved, 169 experimental)

Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every day; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Paranoid Disorders1 drug (1 approved)

Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state.

Schizophrenia, Paranoid10 drugs (7 approved, 3 experimental)

A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination.